| 12th May 2026 1:02 pm |
PRN |
Net Asset Value(s) |
| 11th May 2026 1:33 pm |
PRN |
Net Asset Value(s) |
| 8th May 2026 5:21 pm |
PRN |
Transaction in Own Shares |
| 8th May 2026 1:56 pm |
PRN |
Net Asset Value(s) |
| 7th May 2026 12:58 pm |
PRN |
Net Asset Value(s) |
| 6th May 2026 2:09 pm |
PRN |
Net Asset Value(s) |
| 5th May 2026 1:49 pm |
PRN |
Net Asset Value(s) |
| 1st May 2026 5:32 pm |
PRN |
Compliance with Market Abuse Regulation |
| 1st May 2026 5:20 pm |
PRN |
Transaction in Own Shares |
| 1st May 2026 2:47 pm |
PRN |
ARCHIMED to acquire BIOG portfolio company, Esperion Therapeutics. |
| 1st May 2026 1:37 pm |
PRN |
Net Asset Value(s) |
| 1st May 2026 9:48 am |
PRN |
Total Voting Rights |
| 30th Apr 2026 1:16 pm |
PRN |
Net Asset Value(s) |
| 29th Apr 2026 2:31 pm |
PRN |
Net Asset Value(s) |
| 28th Apr 2026 1:12 pm |
PRN |
Net Asset Value(s) |
| 27th Apr 2026 1:08 pm |
PRN |
Net Asset Value(s) |
| 24th Apr 2026 5:40 pm |
PRN |
Transaction in Own Shares |
| 24th Apr 2026 1:51 pm |
PRN |
Net Asset Value(s) |
| 23rd Apr 2026 1:10 pm |
PRN |
Net Asset Value(s) |
| 22nd Apr 2026 3:05 pm |
PRN |
Net Asset Value(s) |
| 21st Apr 2026 11:45 am |
PRN |
Net Asset Value(s) |
| 20th Apr 2026 2:28 pm |
PRN |
Net Asset Value(s) |
| 17th Apr 2026 5:23 pm |
PRN |
Transaction in Own Shares |
| 17th Apr 2026 2:38 pm |
PRN |
Net Asset Value(s) |
| 16th Apr 2026 1:21 pm |
PRN |
Net Asset Value(s) |
| 15th Apr 2026 12:59 pm |
PRN |
Net Asset Value(s) |
| 14th Apr 2026 12:46 pm |
PRN |
Net Asset Value(s) |
| 13th Apr 2026 1:44 pm |
PRN |
Net Asset Value(s) |
| 13th Apr 2026 10:31 am |
PRN |
Monthly Fact Sheet as at 31 March 2026 |
| 10th Apr 2026 5:23 pm |
PRN |
Transaction in Own Shares |
| 10th Apr 2026 2:36 pm |
PRN |
Net Asset Value(s) |
| 9th Apr 2026 1:22 pm |
PRN |
Net Asset Value(s) |
| 8th Apr 2026 3:05 pm |
PRN |
Net Asset Value(s) |
| 7th Apr 2026 1:08 pm |
PRN |
Net Asset Value(s) |
| 2nd Apr 2026 5:01 pm |
PRN |
Transaction in Own Shares |
| 2nd Apr 2026 2:23 pm |
PRN |
Net Asset Value(s) |
| 1st Apr 2026 4:16 pm |
PRN |
Net Asset Value(s) |
| 1st Apr 2026 9:59 am |
PRN |
Total Voting Rights |
| 1st Apr 2026 7:00 am |
PRN |
Biogen, Inc. to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc. |
| 31st Mar 2026 12:42 pm |
PRN |
Net Asset Value(s) |
